Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 26 July 2027
- Last conf. stmt
- 12 July 2026
Laverock Therapeutics Limited
- Incorporated
- 13 July 2021 (5 years)
- Previously known as
- Skylark Therapeutics Limited (until 22 August 2022)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Natalia Novac
- Accounts type
- Small
- Region
- South East
- Address
- C/o Xeinadin First Floor Secure HouseLulworth CloseChandler's FordSO53 3TL
Officers 6 active
Officer details are public data from the Companies House register.
American
Born April 1971 (55)
Novac, Natalia
Director · Appointed 19 September 2025
German
Born March 1974 (52)
Elsley, Anne-Marie Louise Soeiro
Secretary · Appointed 19 July 2024
British
Born September 1971 (55)
Director · Appointed 22 December 2021
Also at Censo Biotechnologies Ltd · more companies
British
Born December 1966 (59)
Gershon, Gilad Moshe
Director · Appointed 13 July 2021
Israeli,Portuguese
Born January 1982 (44)
Officer history (7 former)
21 April 2026
Resigned Brown, John Robert as Director
8 December 2025
19 September 2025
Appointed Novac, Natalia as Director
1 September 2025
Resigned Noonberg, Sarah as Director
4 April 2025
Appointed Noonberg, Sarah as Director
2 November 2024
19 July 2024
Resigned Caw, Rosheen as Secretary
19 July 2024
Appointed Elsley, Anne-Marie Louise Soeiro as Secretary
27 September 2023
27 September 2023
27 September 2023
27 September 2023
Resigned Boglioli, Elsy as Director
2 February 2022
Appointed Boglioli, Elsy as Director
2 February 2022
Appointed Caw, Rosheen as Secretary
2 February 2022
Appointed Brown, John Robert as Director
2 February 2022
Resigned Rowles, Jamie Michael as Secretary
22 December 2021
22 December 2021
13 July 2021
Appointed Gershon, Gilad Moshe as Director
13 July 2021
Appointed Rowles, Jamie Michael as Secretary
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (1)
29 September 2023
Ceased Tropic Biosciences UK Limited — Holds 25–50% of voting rights
Financials
Figures from 2022 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£2,088,522)
- Employees
- 6
- Debt Ratio
- 219%
- Current Ratio
- 3.8x
Balance sheet detail
| 2022 | |
|---|---|
| Fixed Assets | £435,917 |
| Current Assets | £1,324,549 |
| Creditors (< 1 year) | £352,558 |
| Creditors (> 1 year) | £3,314,625 |
| Net Current Assets | £1,019,210 |
| Net Assets | (£2,088,522) |
| Shareholder Funds | (£2,088,522) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 August 2026 | Resolutions | |||
| 14 August 2026 | Resolutions | |||
| 11 August 2026 | Confirmation statement with updates | 12 July 2026 | ||
| 10 August 2026 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →